Brief: Ensysce Biosciences Announces Clinical Trial Progress Of Its New Class Of Opioids

Ensysce Biosciences

30/11/2021 14:05

Nov 30 (Reuters) - Ensysce Biosciences Inc  ENSC.O :
    * ENSYSCE BIOSCIENCES ANNOUNCES CLINICAL TRIAL PROGRESS OF
ITS NEW
CLASS OF OPIOIDS
    * ENSYSCE BIOSCIENCES - AFTER CONCLUSION OF COHORT, EXPECTS
TO
ENTER BIOEQUIVALENCE STAGE OF STUDY IN JAN 2022
    * ENSYSCE BIOSCIENCES INC - DATA EXPECTED FROM MAD STUDY IN
Q1 OF
2022 AND FROM BE STUDY IN Q2 OF 2022

Source text for Eikon:  ID:nGNX8Qq7bb 
Further company coverage:  ENSC.O 

 ((Reuters.Briefs@thomsonreuters.com;))